Topic: Eua

Maria Bartiromo and Senator Ron Johnson discuss the FDA's updated stance on Ivermectin, which now acknowledges the drug's use for COVID-19. The hosts note that acknowledging effective treatments earlier would have legally prevented the Emergency Use Authorization (EUA) for vaccines. The segment concludes with a final reminder of the September 11th anniversary and the "found passport" narrative.

The FDA recently authorized updated COVID-19 boosters from Pfizer and Moderna despite a lack of detailed clinical data in the submission. Dr. Paul Offit, a member of the FDA advisory panel, voiced dissent, claiming the "fix was in" because the government ordered 105 million doses the day after the vote. Offit criticized the process for relying on press-release-level data rather than the typical 100-page thorough reviews.

A producer from Valparaiso, Indiana, notes that the Emergency Use Authorization for certain PCR tests expired at the end of 2021, suggesting a rush to use up existing inventory. The segment also mentions the FLCCC's recommendation of black cumin seed (Nigella Sativa) as a potential alternative for those unable to access Ivermectin.

The legal framework for Emergency Use Authorization (EUA) is examined, noting that such authorization requires the absence of an approved alternative. There is speculation that the FDA avoids full approval of certain vaccines to maintain the EUA status for the broader market.

Pfizer has formally requested Emergency Use Authorization (EUA) from the FDA for its COVID-19 vaccine for children aged 5 to 11. The proposed regimen is a lower dose than the adult version, tested in a "bridging clinical trial" of 3,000 children. The FDA is scheduled to meet on October 26th to review the safety and efficacy data.

The University of California, Berkeley, and other institutions are moving to mandate COVID-19 vaccines despite their current status under Emergency Use Authorization (EUA). Dr. Francis Collins noted that while the government is not yet mandating shots for NIH employees, he expects mandates to become standard for healthcare workers once full FDA approval is granted. Critics argue that mandating a product under EUA is legally questionable.

The U.S. housing market is facing severe supply chain disruptions, with lumber and pressed wood prices skyrocketing due to reported issues with Chinese imports. In the medical field, a legal argument suggests that the FDA cannot legally maintain "Emergency Use Authorization" for vaccines if effective treatments like Ivermectin or Hydroxychloroquine are available. This has led to a perceived suppression of treatment data to protect the legal status of the vaccine rollout.

Legal scholars and medical ethics professors are debating whether employers can legally mandate vaccines that are only available under Emergency Use Authorization (EUA) rather than full FDA approval. While the EEOC has provided some guidance, the situation remains ambiguous as to whether private companies can terminate employees for refusing the shot.